A free two-day event in Cambridge will unite experts to discuss translational advances in cell and gene therapy, spanning rare diseases, cancer immunotherapy, and genome editing.

Sickle cell patients and their families are speaking out, saying their pain is being treated with a one-size-fits-all ...

Farrell High School students are raising awareness for an important cause--donating blood for sickle cell anemia.

Chronic pain in young people with sickle cell disease means greater disability, more burden, and lower quality of life, a U.S ...

DENVER, Jan. 28, 2026 (GLOBE NEWSWIRE) -- CRISPR gene-editing, and related genome engineering technologies, are reshaping industries from medicine to materials, with breakthroughs in treating genetic ...

Under the agreement, participating states will receive “discounts and rebates” from the drugmakers if the treatments don’t ...

A new CRISPR-based one-off procedure that lowers "bad" cholesterol has been approved to enter Phase I human trial. If ...

Olori Roseline Aladejare representing Oba Dr Emmanuel Adesanya Aladejare Agunsoye II, the Alaaye of Efon Alaaye, Ekiti State, praised Falusi’s resilience, her awareness programme on sickle cell ...

The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...

Columnist Michelle Harlan, who's currently taking hydroxyurea to treat her sickle beta-zero thalassemia, considers some other ...

Join the ELRIG conference to hear from experts on cell and gene therapy. Discover advancements shaping the future of medicine.